Sound Bioventures

Sound Bioventures is a Venture Capital firm that Invests in private clinical-stage biotherapeutics companies in Europe and the USA. The fund has a geographic footprint on both sides of the Atlantic and will support the clinical development of novel medicines for diseases of high unmet medical need. Our investment and portfolio construction strategy builds on lessons learned and approaches perfected during the 15 years the founding team worked together. We invest in companies that are about to enter the most value-generating phase of drug development i.e. clinical stage. Our capital helps answer the question “Is there a drug that works here?” We can lead, co-lead, or follow. We (almost) always take Board seats in companies we invest in and lay particular emphasis on aligning our investment objectives with fellow investors’ investment interests. We always reserve capital for future capital raises and do not do investments in which we cannot. We invest in companies where it is possible for a private investor or venture syndicate to finance the R&D program all the way to regulatory approval.